Northwestern Polytechnic University

Similar documents
UC DavisTB Screening Requirement: How to submit your TB Health Assessment Form

Fundamentals of Tuberculosis (TB)

2017/2018 Annual Volunteer Tuberculosis Notice

PREVENTION OF TUBERCULOSIS. Dr Amitesh Aggarwal

Tuberculosis Tools: A Clinical Update

Latent Tuberculosis Infection Reporting Instructions for Civil Surgeons Using CalREDIE Provider Portal

INDEX CASE INFORMATION

Tuberculosis (TB) Fundamentals for School Nurses

TUBERCULOSIS. Presented By: Public Health Madison & Dane County

Santa Clara County Tuberculosis Screening Requirement for School Entrance Effective June 1, 2014

Targeted Testing and the Diagnosis of. Latent Tuberculosis. Infection and Tuberculosis Disease

LATENT TUBERCULOSIS. Robert F. Tyree, MD

HEALTH SERVICES POLICY & PROCEDURE MANUAL

Screening and Treatment Recommendations for Persons Exposed to MDR TB

Peggy Leslie-Smith, RN

Why need to havetb Clearance. To Control and Prevent Tuberculosis

Tuberculosis and Diabetes Mellitus. Lana Kay Tyer, RN MSN WA State Department of Health TB Nurse Consultant

Diagnosis and Medical Management of Latent TB Infection

What you need to know about diagnosing and treating TB: a preventable, fatal disease. Bob Belknap M.D. Denver Public Health November 2014

Latent Tuberculosis Best Practices

MEMORANDUM. Re: Guidance for follow-up of newly-arrived individual with Class B1 Tuberculosis Pulmonary Tuberculosis, no treatment

Diagnosis and Treatment of Tuberculosis, 2011

Let s Talk TB A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year

Making the Diagnosis of Tuberculosis

Tuberculosis What you need to know. James Zoretic M.D., M.P.H. Regions 2 and 3 Director

Core Curriculum on Tuberculosis: What the Clinician Should Know

TB: Management in an era of multiple drug resistance. Bob Belknap M.D. Denver Public Health November 2012

Communicable Disease Control Manual Chapter 4: Tuberculosis

Healthcare Requirements for Health Science Students To Be Completed by your Primary Healthcare Provider

New Entrant Screening and Latent TB Get screened and find out if you have TB infection before you develop TB disease!

Clinical Practice Guideline

Pediatric Tuberculosis Lisa Y. Armitige, MD, PhD September 14, 2017

Tuberculosis Screening and Targeted Testing of College and University Students: Developing a Best Practice Approach:

TB in the Patient with HIV

10/3/2017. Updates in Tuberculosis. Global Tuberculosis, WHO 2015 report. Objectives. Disclosures. I have nothing to disclose

Contact Investigation and Prevention in the USA

Understanding and Managing Latent TB Infection Arnold, Missouri October 5, 2010

Tuberculosis: A Provider s Guide to

Tuberculosis Reporting, Waco-McLennan County Public Health District TB Control WMCPHD (254)

Chapter 5 Treatment for Latent Tuberculosis Infection

MEMORANDUM. Re: Guidance for follow-up of newly-arrived Individual with a Class B1 Tuberculosis Extrapulmonary Tuberculosis

TB in Corrections Phoenix, Arizona

Please distribute a copy of this information to each provider in your organization.

TB Clinical Guidelines: Revision Highlights March 2014

Community pharmacy-based tuberculosis skin testing

Latent Tuberculosis Infection (LTBI) Questions and Answers for Health Care Providers

Treatment of TB Infection Lisa Y. Armitige, MD, PhD April 7, 2015

CHILDHOOD TUBERCULOSIS: NEW WRINKLES IN AN OLD DISEASE [FOR THE NON-TB EXPERT]

Tuberculosis (TB) and Infection Control PICNET Conference April 12, 2013

Table 9. Policy for Tuberculosis Surveillance and Screening

Guidelines for. Tuberculosis (TB) Screening and. Treatment of Patients with. Chronic Kidney Disease(CKD), Patients Receiving Hemodialysis (HD),

ESCMID Online Lecture Library. by author

TB Intensive San Antonio, Texas May 7-10, 2013

Revised Technical Instructions for Civil Surgeons. October 9, 2018

TB the basics. (Dr) Margaret (DHA) and John (INZ)

TB Skin Test Practicum Houston, Texas Region 6/5 South September 23, 2014

Diagnosis Latent Tuberculosis. Disclosures. Case

Primary Care and TB Control Dr Helen Booth Consultant Thoracic Physician, UCLH Clinical Lead, Integrated TB NCL-Service

TUBERCULOSIS. Pathogenesis and Transmission

Tuberculosis in Chicago 2007

Latent TB, TB and the Role of the Health Department

Tuberculosis Populations at Risk

Diagnosis and Medical Management of TB Infection Lisa Y. Armitige, MD, PhD September 12, TB Nurse Case Management September 12 14, 2017

Stop TB Poster (laminated copies are available from TB Control: )

Self-Study Modules on Tuberculosis

Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis

Preventing Tuberculosis (TB) Transmission in Ambulatory Surgery Centers. Heidi Behm, RN, MPH TB Controller HIV/STD/TB Program

Tuberculosis Intensive

CDC IMMIGRATION REQUIREMENTS:

Monica Manandhar. 2 ND YEAR RESEARCH ELECTIVE RESIDENT S JOURNAL Volume V, A. Study Purpose and Rationale

CHAPTER 3: DEFINITION OF TERMS

Tuberculosis and Diabetes Dec. 10, 2009 Dean Schillinger, M.D. and Gisela Schecter, M.D., M.P.H. 1 of 18

Proposed Regs.pdf

(a) Infection control program. The facility must establish an infection control program under which it--

Tuberculosis Facts. TB is not spread by: Sharing food and drink Shaking someone s hand Touching bed lines or toilet seats

Tuberculosis: Where Are We Now?

Chapter 4 Diagnosis of Tuberculosis Disease

Symptoms Latent TB Active TB

Replaces: 02/11/16. Formulated: 7/95 EMPLOYEE TB TESTING

Latent tuberculosis infection

Vice Chancellor, Health Affairs & Dean, School of Medicine Vice Chancellor & Dean s Office Origination Date: 05/20/2013 Date of Revision: Scope:

Disclosures. Updates in TB for the PCP: Opportunities for Prevention. Objectives PART 1: WHY TEST? 4/14/2016. None

FLORIDA DEPARTMENT OF JUVENILE JUSTICE DETENTION SERVICES FACILITY MEDICAL POLICIES

TUBERCULOSIS IN HEALTHCARE SETTINGS Diana M. Nilsen, MD, FCCP Director of Medical Affairs, Bureau of Tuberculosis Control New York City Department of

TB Intensive San Antonio, Texas. TB/HIV Co-Infection. Lisa Armitige, MD, PhD has the following disclosures to make:

Summary of Immunization Options

MUSC Student Pre-Matriculation Requirements Instructions for Completion of Form

Director, University Health Services. Medical Director

TB: A Supplement to GP CLINICS

Communicable Disease Control Manual Chapter 4: Tuberculosis. Assessment and Follow-Up of TB Contacts

TB Nurse Case Management San Antonio, Texas July 18 20, 2012

Advanced Concepts in Pediatric Tuberculosis

The Most Widely Misunderstood Test of All

New Tuberculosis Guidelines. Jason Stout, MD, MHS

TB is Global. Latent TB Infection (LTBI) Sharing the Care: Working Together. September 24, 2014

TO BE COMPLETED BY APPLICANT. Name: Age: Birth Date: (First) (M.I.) (Last) Home Address: (Number and Street) (City) (State) (Zip) Address:

Investigation of Contacts of Persons with Infectious Tuberculosis, 2005

ATTACHMENT 2. New Jersey Department of Health Tuberculosis Program FREQUENTLY ASKED QUESTIONS

Pediatric TB Lisa Armitige, MD, PhD September 28, 2011

Transcription:

Clinical Tuberculosis Assessment by Health Care Provider Clinicians should review and verify the information in the Tuberculosis (TB) Screening Questionnaire (attached). Persons answering YES to any questions in the TB Screening Questionnaire should receive either a Mantoux Tuberculin Skin Test (TST) or Interferon Gamma Release Assay (IGRA), unless a previous positive test has been documented. For patients with no history of TB, provider must complete Section I (p. 1-3). For patients with a history of prior or current TB (for active disease or latent infection), provider must complete Section II (p. 4-7). History of a positive TST or IGRA? (If yes, provide copy of laboratory report) History of BCG vaccination? (If yes, IGRA is preferred) History of prior or current TB Treatment? (If yes, proceed to section II) Yes No Yes No Yes No SECTION I. No History of Prior or Current TB Treatment 1. TB Symptom Check Does the student have any of the following signs or symptoms of active pulmonary tuberculosis disease? If yes, check below and evaluate to exclude active tuberculosis disease including (1) TB test, (2) chest x- ray, and (3) sputum evaluation. GO TO SECTION II. Cough > 2 weeks Coughing up blood (hemoptysis) Chest pain Loss of appetite Unexplained weight loss Night sweats Fever If no, proceed to TB test 2. TB Test: Tuberculin Skin Test (TST) or Interferon Gamma Release Assay (IGRA) Tuberculin Skin Test (TST) (TST result should be recorded as actual millimeters (mm) of induration, transverse diameter; if no induration, write 0. The TST interpretation should be based on mm of induration as well as risk factors.)* Date Placed: / / Date Read: / / Result: mm of induration *Interpretation: positive negative *Interpretation guidelines 5 mm induration is positive: Recent close contacts of an individual with infectious TB persons with fibrotic changes on a prior chest x-ray, consistent with past TB disease organ transplant recipients and other immunosuppressed persons (including receiving equivalent of >15 mg/d of prednisone for >1 month.) HIV-infected persons Page 1 of 7

10 mm is positive for individuals not listed above (California guidelines) Interferon Gamma Release Assay (IGRA) ATTACH COPY OF LABORATORY REPORT If initially indeterminate or borderline, repeat the test and document below: 3. Chest x-ray: (Required if TST or IGRA is positive) ATTACH COPY OF RADIOLOGY REPORT Date of chest x-ray: / / Interpretation: normal abnormal If chest -ray is normal, proceed to I (4) Management of latent TB infection If chest -ray is abnormal consistent with active TB, further TB evaluation is required. Go to Section II, Evaluation for Students with Symptoms or Signs of TB Disease 4. Management of Latent TB Infection (LTBI) All students with a positive TST or IGRA who have been fully evaluated and active disease has been ruled out should be treated for LTBI. Student accepts (complete section II) Student declines Page 2 of 7

Provider Attestation Northwestern Polytechnic University By signing below, the evaluating provider attests that: (1) The student has no symptoms or signs of active TB and (2) the student is not currently infectious for TB. Provider Name (Please Print) Provider Signature Date Provider Address Provider Telephone Number Page 3 of 7

SECTION II. Evaluation for Students with Symptoms or Signs of TB Disease OR History of Prior or Current Treatment for TB Infection or Disease Complete evaluation or review applicable to student s TB status Required evaluation Symptoms or signs of active TB Currently on for TB disease Prior history of TB disease, completed Currently on for LTBI Prior history of completed for LTBI Provider review of symptoms (section 1) Provider documentation of specific details (section 2) TB testing Prior history of positive TB test, no Chest x-ray within 6 months (section 3) 3 sputa for AFB smear, current (section 4) Prior chest x-ray records (section 5) Prior sputum AFB smear and culture results (section 5) Provider attestation that student has no symptoms or signs of active TB Provider attestation that student is not currently infectious for TB Clinician reports TB case to Public Health within 1 working day Student to bring all original TB diagnostic, microbiology, x-ray and records Student to bring copies of chest and other radiographic images Page 4 of 7

1. TB Symptom Check Does the student have any of the following signs or symptoms of active pulmonary tuberculosis disease? If yes, check below and evaluate to exclude active tuberculosis disease including (1) TB test, (2) chest x- ray, and (3) sputum evaluation. Cough >2 weeks Coughing up blood (hemoptysis) Chest pain Loss of appetite Unexplained weight loss Night sweats Fever 2. TB Test: Tuberculin Skin Test (TST) or Interferon Gamma Release Assay (IGRA) Tuberculin Skin Test (TST) (TST result should be recorded as actual millimeters (mm) of induration, transverse diameter; if no induration, write 0. The TST interpretation should be based on mm of induration as well as risk factors.)* Date Placed: / / Date Read: / / Result: mm of induration *Interpretation: positive negative Interferon Gamma Release Assay (IGRA) ATTACH COPY OF LABORATORY REPORT If initially indeterminate or borderline, repeat the test and document below: Page 5 of 7

3. Treatment Details Treatment for (select one): Active TB Disease or Latent TB Infection Date Treatment Initiated: / / Date Treatment Completed (or anticipated completion date): / / Student s Current Weight: (kg) Name of Medication Isoniazid Rifampin Rifamate Rifabutin Pyrazinamide Ethambutol Vitamin B-6 Strength (mg) Number of Tablets Frequency (qd, biw, tiw, etc.) Total Dosage Route (PO, IV, IM) Date Started Date Stopped 3. Chest and other imaging: (Chest x-ray required within 6 months of start of term) ATTACH COPY OF RADIOLOGY REPORTS Date of Imaging (Month/Day/Year) Anatomical region/image type, e.g., chest x-ray, chest CT Findings Interpretation (normal, abnormal) Page 6 of 7

4. Microbiology: AFB Smear and Culture ATTACH COPIES OF LABORATORY RESULTS Collection date Specimen type Smear result Culture result Susceptibility results 5. Provider Attestation: By signing below, the evaluating provider attests that: (1) The student has no symptoms or signs of active TB (or if currently under for active TB, is asymptomatic) and (2) the student is not currently infectious for TB. Provider Name (Please Print) Provider Signature Date Provider Address Provider Telephone Number Page 7 of 7